Análisis de factores de riesgo de gravedad de la coqueluche en un hospital pediátrico

Ruvinsky, S; Mónaco, A; Perez, G; Della Latta, P; Verdaguer, V; Venuta, M; Motto, E; Weller, G; Lopardo, H; Bologna, R.
Med. infant ; 15(4): 307-311, dic. 2008. tab
Artigo em Espanhol | LILACS, BINACIS, UNISALUD | ID: lil-541259

Similares

  1. [Does the morbidity on pertussis depend on the type and number of vaccines used to immunize? analysis of data from epidemiological surveillance in 2012-2016].
  2. How immunology can help reverse the pertussis vaccine failure.
  3. Repeated Bordetella pertussis Infections Are Required to Reprogram Acellular Pertussis Vaccine-Primed Host Responses in the Baboon Model.
  4. Attitudes of East Tennessee residents towards general and pertussis vaccination: a qualitative study.
  5. Non-primate animal models for pertussis: back to the drawing board?
  6. The effectiveness of maternal pertussis vaccination for protecting Aboriginal and Torres Strait Islander infants against infection, 2012-2017: a retrospective cohort study.
  7. Development of carbohydrate based next-generation anti-pertussis vaccines.
  8. Antigen Discovery for Next-Generation Pertussis Vaccines Using Immunoproteomics and Transposon-Directed Insertion Sequencing.
  9. Mortality risk factors among hospitalized children with severe pertussis.
  10. Whole-Cell and Acellular Pertussis Vaccine: Reflections on Efficacy.